Trastuzumab deruxtecan (T-DXd; DS-8201a) vs. trastuzumab emtansine (T-DM1) in patients (pts) with HER2+metastatic breast cancer (mBC): subgroup analyses from the randomized phase 3 study DESTINY-Breast03

Sara Hurvitz,Sung-Bae Kim,Wei-Pang Chung,Seock-Ah Im,Yeon Hee Park,Roberto Hegg,Min-Hwan Kim,Ling-Ming Tseng,Vanessa Petry,Chi-Feng Chung,Hiroji Iwata,Erika Hamilton,Giuseppe Curigliano,Binghe Xu,Caleb Lee, Yali Liu,Jillian Cathcart,Emarjola Bako,Sunil Verma,Javier Cortes

CANCER RESEARCH（2022）

引用 0|浏览27

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要